DOCSLIB.ORG

(Fx Peptide) Is a Potent Regulator of Actin Polymerization in Living Cells (Cytoskeleton/Assembbly) MITCHELL C

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
(Fx Peptide) Is a Potent Regulator of Actin Polymerization in Living Cells (Cytoskeleton/Assembbly) MITCHELL C Proc. Natl. Acad. Sci. USA Vol. 89, pp. 4678-4682, May 1992 Cell Biology Thymosin 134 (Fx peptide) is a potent regulator of actin polymerization in living cells (cytoskeleton/assembbly) MITCHELL C. SANDERS*, ALLAN L. GOLDSTEINt, AND Yu-Li WANG*t *Cell Biology Group, Worcester Foundation for Experimental Biology, 222 Maple Avenue, Shrewsbury, MA 01545; and tDepartment of Biochemistry and Molecular Biology, The George Washington University School of Medicine and Health Services, Washington, DC 20037 Communicated by Paul C. Zamecnik, February 3, 1992 ABSTRACT Thymosin .84 (f84) is a 5-Ala polypeptide bind a significant portion of monomeric actin and inhibit originally identified in calf thymus. Although numerous activ- salt-induced polymerization of actin filaments in vitro (22, ities have been attributed to .34, its physiological role remains 23). Since (4 appears to be present at a higher level than most elusive. Recently, (34 was found to bind actin in human platelet other actin sequestration factors in platelets and cultured extracts and to inhibit actin polymerization in vitro, raising the cells (20-23), it is possible that (4 may represent the primary possibility that it may be a physiological regulator of actin factor responsible for the regulation of actin polymerization assembly. To eamine this potential function, we have in- (24). creased the cellular A concentration by mlcroilJecting syn- One approach to test this putative physiological role of(4 thetic (34 into living epitheial cells and fibroblasts. The injec- is to induce the "overexpression" in living cells and to tion induced a diminution ofstress fibers and a dose-dependent examine the subsequent effects on specific structures or depolymerization ofactin filaments as indicated by quantitative functions. In the present study, we have taken this approach image analysis of phaLlodin binding. Our results show that (34 by microinjecting excess synthetic (4 into living epithelial is a potent regulator of actin assembly in living cells. cells and fibroblasts. The effects on actin were then deter- mined by measuring the amount of binding of fluorescent Actin is involved in many important nonmuscle cellular phalloidin with quantitative image analysis. Our results in- processes such as cell locomotion, chemotaxis, phagocyto- dicate that (34 is indeed capable of inducing extensive de- sis, and cytokinesis. Previous studies indicate that the reg- polymerization of actin filaments in living cells. ulation ofthese processes involves the dynamic assembly and disassembly of actin filaments and high-order structures, most likely through the interplay ofa number ofactin-binding MATERIALS AND METHODS factors (for reviews, see refs. 1-3). However, important Preparation of Thymosins. (3 and thymosin a, (a,), pro- questions remain concerning the actual mechanism for the vided by Alpha 1 Biomedicals (Washington), were synthe- regulation of actin assembly in living cells. sized as described (25, 26). The concentration of 4 was One important mechanism for the regulation of actin as- determined by the bicinchoninic acid assay (BCA; Sigma) sembly involves the inhibition of spontaneous polymeriza- with bovine serum albumin as the reference and was cali- tion of the high concentration of actin subunits in nonmuscle brated with amino acid analysis of (4. cells. Previously we have demonstrated that such inhibition Actin Polymerization Assay. The activity of synthetic P4 in is probably achieved through the sequestration of actin vitro was determined by the pyrene-conjugated actin assay. monomers from addition onto active sites of assembly (4). Pyrene-actin was prepared as described by Kouyama and However, although a number of monomer sequestering pro- Mihashi (27) with minor modifications (28). The pyrene-actin teins, such as profilin, actin-depolymerizing factor/destrin, conjugate had a dye-to-protein molar ratio of 1.3. Labeled depactin, actobindin, and cofilin, have been identified (5-10), and unlabeled actin monomers were dialyzed for 2-3 days none of these factors appears to be present at a high enough with three exchanges of G-buffer (0.5 mM ATP/0.2 mM concentration to account for the levels of unpolymerized CaCl2/0.5 mM dithiothreitol/2 mM Tris HCl, pH 7.0) and actin in nonmuscle cells. In addition, despite their ability in then centrifuged at 35,000 rpm in a 42.2 Ti rotor at 40C for 2 vitro to inhibit the polymerization of purified actin subunits, hr. Pyrene-actin was mixed 1:20 (wt/wt) with unlabeled actin the activity in vivo remains in question, since a number of at a final actin concentration of 4.2 puM and incubated with factors are capable of stabilizing actin filaments or overcom- various concentrations of(3 for 10 min. At t=0, the solution ing the sequestration effect (11). was mixed with 0.5 volume of 3x polymerization buffer (6 The newest member to this family of potential actin regu- mM MgCl2/0.3 M KCI/3 mM ATP/75 mM imidazole, pH lators is thymosin (4 ((4), an =5-kDa polypeptide first 7.0), and the fluorescence intensity was measured in a isolated from an extract of calf thymus (12-14). (34 was spectrofluorimeter (LS-3; Perkin-Elmer) at an excitation originally proposed solely as a thymic hormone, based on its wavelength of365 nm and an emission wavelength of407 nm. ability to stimulate the T-lymphocyte terminal deoxynucle- For steady-state readings, the samples were allowed to otidyltransferase after intraperitoneal injection into mice (13, polymerize for 15 hr. 15) and to inhibit macrophage migration at a dosage of 5-500 Cell Culture and Mcroinjection. Normal rat kidney (NRK) pM (16). However, later studies indicated that 84 is present epithelial cells (NRK-52E; American Type Culture Collec- at a relatively high abundance in several tissues (17-19) and tion) were cultured in F12K medium (JRH Biosciences, cell lines (20, 21), raising the possibility that it may also serve Lenexa, KS) supplemented with 10%6 (vol/vol) fetal calf a more ubiquitous role. Recently, (4 was found to be identical serum (JRH Biosciences), 50 pg of streptomycin per ml, and to a small acidic peptide (Fx) in platelet extracts, which can 50 units of penicillin per ml and were maintained at 370C under 5% C02/95% air. Swiss 3T3 cells were cultured as The publication costs of this article were defrayed in part by page charge payment. This article must therefore be hereby marked "advertisement" Abbreviations: (34 and a,, thymosins (4 and a,. in accordance with 18 U.S.C. §1734 solely to indicate this fact. *To whom reprint requests should be addressed. 4678 Downloaded by guest on September 27, 2021 Cell Biology: Sanders et al. Proc. Natl. Acad. Sci. USA 89 (1992) 4679 described (4). The cells were plated on microinjection dishes a (29) 36-40 hr prior to microinjection. For most of the experiments, thymosin peptides were dissolved in 5 mM Tris acetate (pH 6.95) containing 3 mg of .ta~%0.3- fixable fluorescein-conjugated dextran (Molecular Probes) cn per ml at a concentration of 0.48-1.63 mM. High concentra- CU) tions (=20 mg/ml) of either a, or 84 were found to be cytotoxic for =30% of the cells (inducing an apparent disin- 5r 0.2- tegration of the cell as observed under phase optics) and 0 therefore were not included in the analysis. Pressure micro- -W injection was performed as described (4, 30). The average 0 volume of microinjection was estimated to be 2-3% ofthe cell .5 volume by the method of Lee (31) with minor modifications (32). Lamellipodia extension was induced by scraping a conflu- ent cultured monolayer with a Pasteur pipet. Cells along the edge were microinjected following a recovery for 15 min. Fluorescent Staining. Cells were incubated for 1 hr at 370C Time (min) after microinjection, then fixed with 4% formaldehyde, per- b meabilized with acetone, and stained with rhodamine- conjugated phalloidin (Sigma) as described by Sanders and Wang (4). Lamellipodia were fixed and extracted with a 1> 0.5- C special protocol that preserves the highly labile structure (see 6) Fig. 3; ref. 33). Immunofluorescence staining with polyclonal C antibodies against actin (Biomedical Technologies, Stough- et0.4- ton, MA) or myosin II (provided by Keigi Fujiwara, National C0 0 Cardiology Research Center, Osaka) was performed essen- 0 tially as described by Amato et al. (34). Rhodamine- 0.3n conjugated secondary antibodies were obtained from Tago. Microscopy and Image Processing. Fluorescence images were recorded with a Zeiss Axiovert 10 microscope (Zeiss) 0 coupled to a cooled CCD camera (Star I; Photometrics, U- Tucson, AZ) using a 100-W quartz-halogen lamp and either a 25x/NA 0.8 Plan-Neofluar or a 10Ox/NA 1.3 Neofluar objective (Zeiss). Images recorded with the illumination lamp 4 offwere subtracted from integrated fluorescence images with a digital image processor. The boundary of injected and #4 (AsM) uninjected sister cell pairs was defined interactively by using a graphics tablet and computer software developed in this FIG. 1. Inhibition ofactin polymerization by synthetic (4 in vitro. Actin polymerization was measured by the increase of fluorescence laboratory. The intensities ofpixels within the boundary were intensity ofpyrene-labeled actin. The assay mixture contains 4.2 AM then integrated with a computer. The percentage of actin total actin and 5% pyrene-actin. The lag period for nucleation was depolymerization was calculated by dividing the integrated extended from 2 to 3 min for the control (o) to >5 min in the presence rhodamine-phalloidin fluorescence of 84-injected cells with of4 AM P4 (0); the initial rate of filament elongation in the presence that of uninjected sister cells. of 4 AM (e) and 6 MM (A) 84 was also significantly reduced (a). In addition, the level of steady-state polymerization was reduced with a linear dependence on the concentration of (34 (b).
Load more

Recommended publications
  • Joy Wellness Partners 838 W G Street Suite 201 San Diego, California 92101
    United States of America FEDERAL TRADE COMMISSION Southwest Region 1999 Bryan St., Ste. 2150 Dallas, Texas 75201 June 3, 2020 WARNING LETTER VIA EMAIL TO [email protected] Joy Wellness Partners 838 W G Street Suite 201 San Diego, California 92101 Re: Unsubstantiated Claims for Coronavirus Prevention or Treatment To Whom It May Concern, This is to advise you that FTC staff reviewed your website at https://joywellnesspartners.com/ on May 24, 2020. We have determined that you are unlawfully advertising that certain products treat or prevent Coronavirus Disease 2019 (COVID-19). Some examples of Coronavirus treatment or prevention claims on your website include: In marketing materials accessible on your website by selecting “BLOG” from the navigation menu and clicking on “CORONAVIRUS (COVID-19),” you claim: o Under the heading “Hormones, Peptides, & Immunity”: . You state that “Keeping your immune system running optimally with balanced hormones and peptides helps your body prevent and fight illness, including viruses like COVID-19. Book now [https://intakeq.com/booking/8hkwjk]” . You post a video titled “IMMUNITY, BIOTE, & CORONAVIRUS” featuring Carol Joy Bender, NP. In the video at approximately 31:55, Bender states, “More specifically, I wanted to touch on the things that we’re all concerned about the coronavirus times: what can I do to boost my immune system to keep me healthy? BioTE has already been doing this for us… We have a lot of patients that are already taking their iodine with selenium and zinc. The zinc is one of the mainstay treatments that many of you have read about… zinc helps to reduce the RNA replication inside the cells, when the coronavirus gets in.
    [Show full text]
  • Endogenous Peptide Discovery of the Rat Circadian Clock a FOCUSED STUDY of the SUPRACHIASMATIC NUCLEUS by ULTRAHIGH PERFORMANCE TANDEM MASS □ SPECTROMETRY* S
    Research Endogenous Peptide Discovery of the Rat Circadian Clock A FOCUSED STUDY OF THE SUPRACHIASMATIC NUCLEUS BY ULTRAHIGH PERFORMANCE TANDEM MASS □ SPECTROMETRY* S Ji Eun Lee‡§, Norman Atkins, Jr.¶, Nathan G. Hatcherʈ, Leonid Zamdborg‡§, Martha U. Gillette§¶**, Jonathan V. Sweedler‡§¶ʈ, and Neil L. Kelleher‡§‡‡ Understanding how a small brain region, the suprachias- pyroglutamylation, or acetylation. These aspects of peptide matic nucleus (SCN), can synchronize the body’s circa- synthesis impact the properties of neuropeptides, further ex- dian rhythms is an ongoing research area. This important panding their diverse physiological implications. Therefore, time-keeping system requires a complex suite of peptide unveiling new peptides and unreported peptide properties is hormones and transmitters that remain incompletely critical to advancing our understanding of nervous system characterized. Here, capillary liquid chromatography and function. FTMS have been coupled with tailored software for the Historically, the analysis of neuropeptides was performed analysis of endogenous peptides present in the SCN of the rat brain. After ex vivo processing of brain slices, by Edman degradation in which the N-terminal amino acid is peptide extraction, identification, and characterization sequentially removed. However, analysis by this method is from tandem FTMS data with <5-ppm mass accuracy slow and does not allow for sequencing of the peptides con- produced a hyperconfident list of 102 endogenous pep- taining N-terminal PTMs (5). Immunological techniques, such tides, including 33 previously unidentified peptides, and as radioimmunoassay and immunohistochemistry, are used 12 peptides that were post-translationally modified with for measuring relative peptide levels and spatial localization, amidation, phosphorylation, pyroglutamylation, or acety- but these methods only detect peptide sequences with known lation.
    [Show full text]
  • Thymosin Hh10 Inhibits Angiogenesis and Tumor Growth by Interfering with Ras Function
    Research Article Thymosin hh10 Inhibits Angiogenesis and Tumor Growth by Interfering with Ras Function Seung-Hoon Lee,1 Myung Jin Son,1,2 Sun-Hee Oh,1 Seung-Bae Rho,1 Kyungsook Park,1 Yung-Jin Kim,2 Mi-Sun Park,1 and Je-Ho Lee1 1Molecular Therapy Research Center, Samsung Medical Center, School of Medicine, Sung Kyun Kwan University, Seoul, Korea and 2Department of Molecular Biology, Pusan National University, Busan, Korea Abstract are a family of highly conserved small peptides that inhibit barbed end actin polymerization by sequestering actin mono- Thymosin h10 is a monomeric actin sequestering protein mers (8). Among them, thymosin h4 and thymosin h10 are the that regulates actin dynamics. Previously, we and others h have shown that thymosin h acts as an actin-mediated two most abundant -thymosins in the mammalian species and 10 coexist in some tissue types at varying ratios (9). Although both tumor suppressor. In this study, we show that thymosin h10 is not only a cytoskeletal regulator, but that it also acts as a peptides share a high degree of sequence homology, they show potent inhibitor of angiogenesis and tumor growth by its distinct patterns of expression in several tissues (10) and play interaction with Ras. We found that overexpressed thymosin different roles during rodent development (11). Recently, the angiogenic effects of several members of the thymosin family of h10 significantly inhibited vascular endothelial growth factor–induced endothelial cell proliferation, migration, peptides were studied in the chick chorioallantoic membrane h a invasion, and tube formation in vitro. Vessel sprouting was model (12).
    [Show full text]
  • Multiple Beneficial Effects of Melanocortin MC4 Receptor
    View metadata, citation and similar papers at core.ac.uk brought to you by CORE provided by Archivio della ricerca - Università degli studi di Napoli Federico II Progress in Neurobiology 148 (2017) 40–56 Contents lists available at ScienceDirect Progress in Neurobiology journal homepage: www.elsevier.com/locate/pneurobio Review article Multiple beneficial effects of melanocortin MC4 receptor agonists in experimental neurodegenerative disorders: Therapeutic perspectives a a a b c Daniela Giuliani , Alessandra Ottani , Laura Neri , Davide Zaffe , Paolo Grieco , d e f a, Jerzy Jochem , Gian Maria Cavallini , Anna Catania , Salvatore Guarini * a Department of Biomedical, Metabolic and Neural Sciences, Section of Pharmacology and Molecular Medicine, University of Modena and Reggio Emilia, Modena, Italy b Department of Biomedical, Metabolic and Neural Sciences, Section of Human Morphology, University of Modena and Reggio Emilia, Modena, Italy c Department of Pharmacy, University of Napoli “Federico II”, Napoli, Italy d Department of Basic Medical Sciences, School of Public Health in Bytom, Medical University of Silesia, Katowice, Poland e Department of Ophthalmology, University of Modena and Reggio Emilia, Modena, Italy f Center for Preclinical Surgical Research, Fondazione IRCCS Ca' Granda À Ospedale Maggiore Policlinico, Milano, Italy A R T I C L E I N F O A B S T R A C T Article history: Received 20 May 2015 Melanocortin peptides induce neuroprotection in acute and chronic experimental neurodegenerative Received in revised form 22 November 2016 conditions. Melanocortins likewise counteract systemic responses to brain injuries. Furthermore, they Accepted 28 November 2016 promote neurogenesis by activating critical signaling pathways. Melanocortin-induced long-lasting Available online 1 December 2016 improvement in synaptic activity and neurological performance, including learning and memory, sensory-motor orientation and coordinated limb use, has been consistently observed in experimental Keywords: models of acute and chronic neurodegeneration.
    [Show full text]
  • Supporting Information for Proteomics DOI 10.1002/Pmic.200700142
    Supporting Information for Proteomics DOI 10.1002/pmic.200700142 Karl Skld, Marcus Svensson, Mathias Norrman, Benita Sjgren, Per Svenningsson and Per E. Andren´ The significance of biochemical and molecular sample integrity in brain proteomics and peptidomics: Stathmin 2-20 and peptides as sample quality indicators ª 2007 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim www.proteomics-journal.com SUPPORTING INFORMATION Supporting Information Table 1. Degraded protein identities and peptide sequences in the striatum after 1, 3, and 10 min post-mortem. UniProtKBa. Protein name Sequenceb Scorec P60710/P63260 Actin, cytoplasmic 1,2 A.LVVDNGSGMCK.A 56 E.MATAASSSSLEKS.Y 55 W.IGGSILASLSTFQQ.M 64 W.ISKQEYDESGPSIVHRK.C 93 M.WISKQEYDESGPSIVHRK.C 56 Q8K021 Secretory carrier-associated F.ATGVMSNKTVQTAAANAASTAATSAAQNAFKGNQM.- 124 membrane protein 1 Q9D164 FXYD domain-containing ion L.ITTNAAEPQK.A 58 transport regulator 6 precursor L.ITTNAAEPQKA.E 57 L.ITTNAAEPQKAE.N 89 L.ITTNAAEPQKAEN.- 54 P99029 Peroxiredoxin 5, mitochondrial M.APIKVGDAIPSVEVF.E 57 precursor P01942 Hemoglobin alpha subunit F.LASVSTVLTSKYR.- 106 M.FASFPTTKTYFPHF.D 72 L.ASHHPADFTPAVHASLDK.F 76 T.LASHHPADFTPAVHASLDK.F 59 L.LVTLASHHPADFTPAVHAS.L 56 L.LVTLASHHPADFTPAVHASLDK.F 71 L.LVTLASHHPADFTPAVHASLDKFLASVST.V 66 T.LASHHPADFTPAVHASLDKFLAS.V 55 L.VTLASHHPADFTPAVHASLDKFLAS.V 68 -.VLSGEDKSNIKAAWGKIGGHGAEYGAEALER.M 97 -.VLSGEDKSNIKAAWGKIGGHGAEYGAEALERM.F 58 P02088/P02089 Hemoglobin beta-1,2 subunit L.LVVYPWTQRY.F 53 L.LVVYPWTQRYF.D 52 Q00623 Apolipoprotein A-I precursor Y.VDAVKDSGRDYVSQFESSSLGQQLN.L
    [Show full text]
  • Information to Users
    INFORMATION TO USERS This manuscript has been reproduced from the microfilm master. UMI films the text directly from the original or copy submitted. Thus, some thesis and dissertation copies are in typewriter face, while others may be from any type of computer printer. The quality of this reproduction is dependent upon the quality of the copy submitted. Broken or indistinct print, colored or poor quality illustrations and photographs, print bleedthrough, substandard margins, and improper alignment can adversely affect reproduction. In the unlikely event that the author did not send UMI a complete manuscript and there are missing pages, these will be noted. Also, if unauthorized copyright material had to be removed, a note will indicate the deletion. Oversize materials (e.g., maps, drawings, charts) are reproduced by sectioning the original, beginning at the upper left-hand comer and continuing from left to right in equal sections with small overlaps. Each original is also photographed in one exposure and is included in reduced form at the back of the book. Photographs included in the original manuscript have been reproduced xerographically in this copy. Higher quality 6" x 9" black and white photographic prints are available for any photographs or illustrations appearing in this copy for an additional charge. Contact UMI directly to order. A Bell & Howell Information Company 300 North Zeeb Road. Ann Arbor. Ml 48106-1346 USA 313/761-4700 800/521-0600 Order Number 9517090 Partial characterization and purification of steroidogenic factors in thymic epithelial cell culture-conditioned medium Uzumcu, Mehmet, Ph.D. The Ohio State University, 1994 UMI 300 N.
    [Show full text]
  • Stabilization Stabilizor Workflow Inactivation of Enzymes
    Denator Novel Tissue Sample Preparation Technology for MS Analysis denator.com WATERS 2nd NORDIC MS SYMPOSIUM Tuesday Nov 8 2011 Båstad Katarina Alenäs Denator 2004 University spin-off 2006 Head office at Biotech Center Gothenburg, Sweden Research lab in Uppsala Science Park, Sweden 2008 Stabilizor T1 – Launch 2009-to date Publications: Svensson et al. “Heat stabilization of the tissue proteome” Journal of Proteome Research, 2009 Robinson et al. “Assessing the use of thermal treatment to preserve the intact proteomes of post-mortem heart and brain tissue” Proteomics, 2009 Scholz et al. “Impact of temperature dependent sampling procedures in proteomics and peptidomics” Molecular and Cellular Proteomics, 2010 Goodwin et al. “Stopping the clock on proteomic degradation by heat-treatment at the point of tissue excision” Proteomics, 2010 Rountree et al “Clinical application for the preservation of phospho-proteins through in-situ tissue stabilization” Proteome Science, 2010 Ahmed et al “Preserving protein profiles in tissue samples: Differing outcomes with and without heat stabilization” Journal of Neuroscience Methods, 2011 Colgrave et al “Neuropeptide profiling of the bovine hypothalamus: Thermal stabilization is an effective tool in inhibiting post-mortem degradation” Colgrave et al, Proteomics, 2011 Protein research workflow Collection Sample prep Analysis Bioinformatics Stabilization Extraction 2D-gels Dissection Clean up MS Storage Enrichment Western blot Transport Trypsin cleavage ELISA Laboratory for Biological and Medical Mass Spectrometry,
    [Show full text]
  • Mass Spectrometry-Based Discovery of Circadian Peptides
    Mass spectrometry-based discovery of circadian peptides Nathan G. Hatcher*†, Norman Atkins, Jr.‡, Suresh P. Annangudi*†, Andrew J. Forbes*, Neil L. Kelleher*§, Martha U. Gillette‡§¶, and Jonathan V. Sweedler*†‡§ ʈ *Department of Chemistry; †Beckman Institute; ‡Neuroscience Program; ¶Department of Cell and Developmental Biology; and §Institute for Genomic Biology, University of Illinois, Urbana, IL 61801 Communicated by William T. Greenough, University of Illinois at Urbana–Champaign, Urbana, IL, May 20, 2008 (received for review January 18, 2008) A significant challenge to understanding dynamic and heteroge- (5–8). Captured releasates then were characterized offline with neous brain systems lies in the chemical complexity of secreted MALDI TOF MS. Following this strategy, releasates could be intercellular messengers that change rapidly with space and time. screened for multiple compounds that include known, unex- Two solid-phase extraction collection strategies are presented that pected, or even unknown compounds. relate time and location of peptide release with mass spectrometric We characterized peptides endogenously secreted from the characterization. Here, complex suites of peptide-based cell-to-cell site of the SCN over the course of 24 h as well as peptides signaling molecules are characterized from the mammalian supra- released specifically following electrophysiological stimulation chiasmatic nucleus (SCN), site of the master circadian clock. Ob- of the retinohypothalamic (RHT) tract, the afferent pathway served SCN releasates are peptide rich and demonstrate the co- mediating SCN phase-setting light cues (9, 10). Surprisingly release of established circadian neuropeptides and peptides with complex SCN neuropeptide release spectra were observed with unknown roles in circadian rhythms. Additionally, the content of the use of a combination of neurophysiology and selective SCN releasate is stimulation specific.
    [Show full text]
  • (12) United States Patent (10) Patent No.: US 8,133,863 B2 Maggio (45) Date of Patent: Mar
    USOO8133863B2 (12) United States Patent (10) Patent No.: US 8,133,863 B2 Maggio (45) Date of Patent: Mar. 13, 2012 (54) STABILIZING ALKYLGLYCOSIDE 3.5. A g E. S. et al COMPOSITIONS AND METHODS THEREOF 5,369,095 A 1 1/1994 KeeOnahoe et al. et al. 5,556,757 A 9, 1996 A1 tal. (75) Inventor: Edward T. Maggio, San Diego, CA 5,556,940 A 9, 1996 WRC (US) 6,524,557 B1 2/2003 Backstrom et al. 6,551.578 B2 * 4/2003 Adjei et al. ..................... 424/45 (73) Assignee: Aegis Therapeutics, LLC, San Diego, 2002fO1105247,425,542 A1B2 9/20088, 2002 CowanMaggio et al. CA (US) 2004/0209814 A1 10, 2004 Nauck et al. 2005/0215475 A1 9/2005 Ong et al. (*) Notice: Subject to any disclaimer, the term of this 2005/0276843 Al 12/2005 Quay et al. patent is extended or adjusted under 35 2006/0046962 A1 3/2006 Meezan et al. .................. 514/12 2006, OO74025 A1 4/2006 Quay et al. U.S.C. 154(b) by 443 days. 2006/0183674 A1 8/2006 Brand et al. 21) Appl. No.: 12/360,758 2007/01 11938 A1 5, 2007 Pert et al. (21) Appl. No.: 9 (Continued) (22) Filed: Jan. 27, 2009 FOREIGN PATENT DOCUMENTS US 2009/0197816A1 Aug. 6, 2009 (Continued) OTHER PUBLICATIONS Related U.S. Application Data Brown et al. Affinity Purification of a Somatostatin Receptor-G- (60) Division of application No. 12/119,378, filed on May protein Complex... The Journal of Biological Chemistry. Mar. 25. 12, 2008, which is a continuation-in-part of 1993, Vol.
    [Show full text]
  • Slow” NGF Binding, Efficient NGF Uptake, and Multiple NGF Responses to NGF-Nonresponsive PC12 Cell Mutants
    The Journal of Neuroscience, July 1993, 13(7): 2919-2929 Transfection with frk Restores “Slow” NGF Binding, Efficient NGF Uptake, and Multiple NGF Responses to NGF-nonresponsive PC12 Cell Mutants David M. Loeb and Lloyd A. Greene Department of Pathology and Center for Neurobiology and Behavior, Columbia University, New York, New York 10032 NGF binds to and activates the protein tyrosine kinase line PC 12 (Greene and Tischler, 1976) has been used extensively gp140prototrk. Expression of this receptor is required for at as an in vitro model to study NGF signaling (Levi et al., 1988). least some responses to NGF. Three outstanding issues are Two distinct NGF receptors, designated ~75 and gp140proto1rk addressed in the present work. First, we determined whether (Trk), have been identified, and cDNAs encoding these have expression of gpl40 protot* is required for all neuronal NGF been cloned (Chao et al., 1986; Radeke et al., 1987; Martin- responses. Second, we examined the role of gp140Pmtot* in Zanca et al., 1989). The discovery that NGF binds to and stim- NGF binding and internalization. Third, we addressed the ulates the tyrosine kinase activity of the gp140~~~‘~‘~~(Bothwell, utility of NGF-nonresponsive PC1 2nnr5 cells for study of the 199 1; Kaplan et al., 199 la,b; Klein et al., 1991) has focused NGF mechanism. In contrast to wild-type PC12 cells, attention on its role in NGF signal transduction. Transfection PC1 2nnr5 cells do not express endogenous gpl40~~~‘~‘*. We experiments have demonstrated that gp140~~~‘~“~mediates NGF- therefore asked whether they possess other defects that stimulated fibroblast transformation (Cordon-Card0 et al., 199 1) compromise NGF signaling pathways.
    [Show full text]
  • Interaction of Dietary Fat and the Thymus in the Induction of Mammary Tumors by 7,12-Dimethylbenz(A)Anthracene1
    [CANCER RESEARCH 42. 1266-1273, April 1982] 0008-5472/82/0042-OOOOS02.00 Interaction of Dietary Fat and the Thymus in the Induction of Mammary Tumors by 7,12-Dimethylbenz(a)anthracene1 David A. Wagner,2 Paul H. Naylor,3 Untae Kim, Wendy Shea, Clement Ip, and Margot M. Ip4 Department of Experimental Therapeutics, Grace Cancer Drug Center [D. A. W., P. H. N., W. S., M. M. I.], and Departments of Pathology [U. KJ and Breast Surgery [C. I.], New York State Department of Health, Roswe/l Park Memorial Institute, Buffalo, New York 14263 ABSTRACT the host, specifically an elevation of serum prolactin levels, might be responsible for this effect (11, 34). Other possibilities The interaction of dietary fat and the thymus in the induction include an effect of dietary fat on the immune system (20, 22, of mammary tumors by dimethylbenz(a)anthracene has been 43), prostaglandins (30), or through maintenance and induction examined in female Sprague-Dawley rats. In these experi of prolactin receptors (42). ments, rats fed diets of 0.5% (low fat), 5% (normal fat), or 20% There is some experimental evidence which indicates that (high fat) corn oil from weaning (21 days of age) were thymec- the thymus can modulate mammary tumorigenesis. For exam tomized or sham thymectomized at 35 days of age and were ple, neonatal thymectomy has been shown to decrease the given 5 mg of dimethylbenz(a)anthracene at 55 days of age. incidence and increase the latency period of spontaneous (58), Thymectomy exerted a protective effect in rats fed low and transplantable (3), and chemical- or virus-induced mammary normal fat diets, and this was not reversed by Thymosin Frac tumors (28, 44, 45, 53, 55, 56, 60, 66).
    [Show full text]
  • Increasing Heart Vascularisation After Myocardial Infarction Using Brain Natriuretic Peptide Stimulation of Endothelial and WT1+ Epicardium- Derived Cells
    bioRxiv preprint doi: https://doi.org/10.1101/2020.07.17.207985; this version posted July 17, 2020. The copyright holder for this preprint (which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission. 1 Increasing heart vascularisation after myocardial infarction using brain natriuretic peptide stimulation of endothelial and WT1+ epicardium- derived cells. Na Li, Stéphanie Rignault-Clerc, Christelle Bielmann, Anne-Charlotte Bon-Mathier, Tamara Déglise, Alexia Carboni, Mégane Ducrest, Nathalie Rosenblatt-Velin* Division of Angiology, Heart and Vessel Department, Centre Hospitalier Universitaire Vaudois and University of Lausanne, Switzerland. Short Title: BNP improves heart neovascularisation Address for correspondance: * Nathalie Rosenblatt-Velin, PhD CHUV, Division d’Angiologie Département Cœur-Vaisseaux Institut de Physiologie, Bugnon 7a, 1005 Lausanne, Switzerland Phone: +41 79 556 76 68 Fax: +41 21 692 55 95 Email: [email protected] bioRxiv preprint doi: https://doi.org/10.1101/2020.07.17.207985; this version posted July 17, 2020. The copyright holder for this preprint (which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission. 2 ABSTRACT Brain natriuretic peptide (BNP) treatment increases heart function and decreases heart dilation after myocardial infarction. Here, we investigated whether part of the cardioprotective effect of BNP in infarcted hearts related to improved neovascularisation. Infarcted mice were treated with saline or BNP for 10 days. BNP treatment increased vascularisation and the number of endothelial cells in the infarct border and remote zones of infarcted hearts. Endothelial cell lineage tracing showed that BNP directly stimulated the proliferation of resident mature endothelial cells in both areas of the infarcted hearts, via NPR-A binding and p38 MAP kinase activation.
    [Show full text]